The 3,4-dioxygenated 5-hydroxy-4-aryl-quinolin-2(1H)-one alkaloids. Results of 20 years of research, uncovering a new family of natural products
- 期刊名称Nat. Prod. Rep.
- 作者Simonetti, Sebastian O.; Larghi, Enrique L.; Kaufman, Teodoro S.
- 印刷ISSN0265-0568
- 电子ISSN1460-4752
- 文件大小1912.39KB
- 发表时间2016
- DOI10.1039/C6NP00064A
EGFR testing in advanced non-small-cell lung cancer, a mini-reviewSheikine, Yuri; Rangachari, Deepa; McDonald, Danielle C.; Huberman, Mark S.; Folch, Erik S.; VanderLaan, Paul A.; Costa, Daniel B. · Clinical Lung Cancer · 2016
Tumor biomarker testing in non-small-cell lung cancer: A decade of changeVanderLaan, Paul A.; Rangachari, Deepa; Majid, Adnan; Parikh, Mihir S.; Gangadharan, Sidharta P.; Kent, Michael S.; McDonald, Danielle C.; Huberman, Mark S.; Kobayashi, Susumu S.; Costa, Daniel B. · Lung Cancer · 2018
Rapidly fatal advanced EGFR-mutated lung cancers and the need for rapid tumor genotyping in clinical practiceRangachari, Deepa; Drake, Lauren; Huberman, Mark S.; McDonald, Danielle C.; VanderLaan, Paul A.; Folch, Erik; Costa, Daniel B. · Cancer Treatment and Research Communications · 2016
Cases of ALK -rearranged lung cancer with 5-year progression-free survival with crizotinib as initial precision therapyRangachari, Deepa; Le, Xiuning; Shea, Meghan; Huberman, Mark S.; VanderLaan, Paul A.; Kobayashi, Susumu S.; Costa, Daniel B. · Journal of Thoracic Oncology · 2017
Activity of brigatinib in the setting of alectinib resistance mediated by ALK -I1171S in ALK rearranged lung cancerSehgal, Kartik; Peters, Mary Linton B.; VanderLaan, Paul A.; Rangachari, Deepa; Kobayashi, Susumu S.; Costa, Daniel B. · Journal of Thoracic Oncology · 2018
Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancersRangachari, Deepa; Yamaguchi, Norihiro; VanderLaan, Paul A.; Folch, Erik; Mahadevan, Anand; Floyd, Scott R.; Uhlmann, Erik J.; Wong, Eric T.; Dahlberg, Suzanne E.; Huberman, Mark S.; Costa, Daniel B. · Lung Cancer · 2015
Detection of Crizotinib-Sensitive Lung Adenocarcinomas With MET, ALK, and ROS1 Genomic Alterations via Comprehensive Genomic ProfilingLe, Xiuning; Freed, Jason A.; VanderLaan, Paul A.; Huberman, Mark S.; Rangachari, Deepa; Jorge, Susan E.; Lucena-Araujo, Antonio R.; Kobayashi, Susumu S.; Balasubramanian, Sohail; He, Jie; Chudnovsky, Yakov; Miller, Vincent A.; Ali, Siraj M.; Costa, Daniel B. · Clinical Lung Cancer · 2015
Non-Coding RNAHuang, Jie; Peng, Juan; Guo, Linlang · Journal of Thoracic Oncology · 2015
In This Issue&NA;, · Journal of Thoracic Oncology · 2014
Early-Stage Lung Cancer&NA;, · Journal of Thoracic Oncology · 2015
An Era of Lung Cancer IconoclastsCarbone, David P. · Journal of Thoracic Oncology · 2014
Histologic Classification of Thymomaden Bakker, Michael A.; Roden, Anja C.; Marx, Alexander; Marino, Mirella · Journal of Thoracic Oncology · 2014
Subject Index&NA;, · Journal of Thoracic Oncology · 2014
In this Issue&NA;, · Journal of Thoracic Oncology · 2014
In This Issue&NA;, · Journal of Thoracic Oncology · 2014